<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">mimmun</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинская иммунология</journal-title><trans-title-group xml:lang="en"><trans-title>Medical Immunology (Russia)</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1563-0625</issn><issn pub-type="epub">2313-741X</issn><publisher><publisher-name>SPb RAACI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.15789/1563-0625-2005-5-6-453-460</article-id><article-id custom-type="elpub" pub-id-type="custom">mimmun-578</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ЛЕКЦИИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>LECTURE</subject></subj-group></article-categories><title-group><article-title>СУПЕРАНТИГЕНЫ - ФАКТОРЫ ПАТОГЕННОСТИ ИЛИ СТИМУЛЯТОРЫ ИММУНИТЕТА</article-title><trans-title-group xml:lang="en"><trans-title>SUPERANTIGENS - PATHOGENICITY FAKTORS OR STIMULATORS OF IMMUNITY?</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Пронин</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Pronin</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>123098, Москва, ул. Гамалеи, д. 18</p></bio><email xlink:type="simple">proninalex@mail.infotel.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff xml:lang="ru" id="aff-1"><institution>ГУ НИИЭМ им. Н. Ф. Гамалеи РАМН, Москва</institution><country>Russian Federation</country></aff><pub-date pub-type="collection"><year>2005</year></pub-date><pub-date pub-type="epub"><day>23</day><month>07</month><year>2014</year></pub-date><volume>7</volume><issue>5-6</issue><fpage>453</fpage><lpage>460</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Пронин А.В., 2014</copyright-statement><copyright-year>2014</copyright-year><copyright-holder xml:lang="ru">Пронин А.В.</copyright-holder><copyright-holder xml:lang="en">Pronin A.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.mimmun.ru/mimmun/article/view/578">https://www.mimmun.ru/mimmun/article/view/578</self-uri><abstract><p>Суперантигены — факторы патогенности или стимуляторы иммунитета.</p></abstract></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Горина Л.Г., Пронин А.В. Частичная очистка и свойства митогенного фактора Mycoplasma arthritidis // Ж. микробиол. эпидемиол. иммунобиол. — 1985. — №10. — С.63–66.</mixed-citation><mixed-citation xml:lang="en">Горина Л.Г., Пронин А.В. Частичная очистка и свойства митогенного фактора Mycoplasma arthritidis // Ж. микробиол. эпидемиол. иммунобиол. — 1985. — №10. — С.63–66.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Езепчук Ю.В., Пронин А.В. Иммунобиологические свойства суперантигенов // Вестник РАМН. – 2000. — №1. — С.38–45.</mixed-citation><mixed-citation xml:lang="en">Езепчук Ю.В., Пронин А.В. Иммунобиологические свойства суперантигенов // Вестник РАМН. – 2000. — №1. — С.38–45.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Мирчинк Е.П., Пронин А.В., Зуев В.А., Деева А.В. Роль супрессорных клеток при врожденной гриппозной инфекции // Вопр. вирусол. — 1988. — №6. — С.659–661.</mixed-citation><mixed-citation xml:lang="en">Мирчинк Е.П., Пронин А.В., Зуев В.А., Деева А.В. Роль супрессорных клеток при врожденной гриппозной инфекции // Вопр. вирусол. — 1988. — №6. — С.659–661.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Пронин А.В., Мирчинк Е.П., Зуев В.А., Деева А.В. Супрессоры интерлейкина–1, не действующие на продукцию интерлейкина–2 при гриппозной инфекции у мышей // Иммунология. — 1989. — №1. — С.29–32.</mixed-citation><mixed-citation xml:lang="en">Пронин А.В., Мирчинк Е.П., Зуев В.А., Деева А.В. Супрессоры интерлейкина–1, не действующие на продукцию интерлейкина–2 при гриппозной инфекции у мышей // Иммунология. — 1989. — №1. — С.29–32.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Пронин А.В., Горина Л.Г. Неспецифические митогенные факторы микоплазм: иммунобиологические свойства // Вестник АМН СССР. — 1991. — №6. — С.30–34.</mixed-citation><mixed-citation xml:lang="en">Пронин А.В., Горина Л.Г. Неспецифические митогенные факторы микоплазм: иммунобиологические свойства // Вестник АМН СССР. — 1991. — №6. — С.30–34.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Пронин А.В., Деева А.В., Зуев В.А., Мирчинк Е.П., Раковская И.В., Ялфимова Е.Ю. Иммунологические последствия врожденных инфекций // Ж. микробиол. эпидемиол. иммунобиол. — 1997. — №4. — С.105–108.</mixed-citation><mixed-citation xml:lang="en">Пронин А.В., Деева А.В., Зуев В.А., Мирчинк Е.П., Раковская И.В., Ялфимова Е.Ю. Иммунологические последствия врожденных инфекций // Ж. микробиол. эпидемиол. иммунобиол. — 1997. — №4. — С.105–108.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Ялфимова Е.Ю., Пронин А.В. Суперантигены и их роль в патологии // Ж. микробиол. эпидемиол. иммунобиол. — 1999. — №3. — С.98–104.</mixed-citation><mixed-citation xml:lang="en">Ялфимова Е.Ю., Пронин А.В. Суперантигены и их роль в патологии // Ж. микробиол. эпидемиол. иммунобиол. — 1999. — №3. — С.98–104.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Ялфимова Е.Ю., Деева А.В., Пронин А.В., Раковская И.В. Влияние суперантигена Mycoplasma arthritidis на иммуногенез при трансплацентарном инфицировании // Ж. микробиол. эпидемиол. иммунобиол. — 1999. — №4. — С.60–62.</mixed-citation><mixed-citation xml:lang="en">Ялфимова Е.Ю., Деева А.В., Пронин А.В., Раковская И.В. Влияние суперантигена Mycoplasma arthritidis на иммуногенез при трансплацентарном инфицировании // Ж. микробиол. эпидемиол. иммунобиол. — 1999. — №4. — С.60–62.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Arad G., Levy R., Kaempfer R. Superantigen concomitantly induces Th1 cytokine genes and the ability to shut off their expression on re–exposure to superantigen // Immunol. Lett. — 2002. — Vol.82. — N1–2. – P.75–78.</mixed-citation><mixed-citation xml:lang="en">Arad G., Levy R., Kaempfer R. Superantigen concomitantly induces Th1 cytokine genes and the ability to shut off their expression on re–exposure to superantigen // Immunol. Lett. — 2002. — Vol.82. — N1–2. – P.75–78.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Azuma K., Koike K., Kobayashi T., Mochizuki T., Mashiko K., Yamamoto Y. Detection of circulating superantigens in an intensive care unit population // Int. J. Infect. Dis. — 2004. — Vol.8. — N5. — P.292–298.</mixed-citation><mixed-citation xml:lang="en">Azuma K., Koike K., Kobayashi T., Mochizuki T., Mashiko K., Yamamoto Y. Detection of circulating superantigens in an intensive care unit population // Int. J. Infect. Dis. — 2004. — Vol.8. — N5. — P.292–298.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Baker M.D., Acharya K.R. Superantigens: structure–function relationships // Int. J. Med. Microbiol. — 2004. — Vol.293. — N7–8. — P.529–537.</mixed-citation><mixed-citation xml:lang="en">Baker M.D., Acharya K.R. Superantigens: structure–function relationships // Int. J. Med. Microbiol. — 2004. — Vol.293. — N7–8. — P.529–537.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Baker H.M., Proft T., Webb P.D., Arcus V.L., Fraser J.D., Baker E.N. Crystallographic and Mutational Data Show That the Streptococcal Pyrogenic Exotoxin J Can Use a Common Binding Surface for T–cell Receptor Binding and Dimerization // J. Biol. Chem. — 2004. — Vol. 279. — N.37. — P.38571–38576.</mixed-citation><mixed-citation xml:lang="en">Baker H.M., Proft T., Webb P.D., Arcus V.L., Fraser J.D., Baker E.N. Crystallographic and Mutational Data Show That the Streptococcal Pyrogenic Exotoxin J Can Use a Common Binding Surface for T–cell Receptor Binding and Dimerization // J. Biol. Chem. — 2004. — Vol. 279. — N.37. — P.38571–38576.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Brandt K., van der Bosch J., Fliegert R., Gehring S. TSST–1 induces Th1 or Th2 differentiation in naive CD4+ T cells in a dose– and APC–dependent manner / / Scand. J. Immunol. — 2002. — Vol.56. — N 6. — P.572–579.</mixed-citation><mixed-citation xml:lang="en">Brandt K., van der Bosch J., Fliegert R., Gehring S. TSST–1 induces Th1 or Th2 differentiation in naive CD4+ T cells in a dose– and APC–dependent manner / / Scand. J. Immunol. — 2002. — Vol.56. — N 6. — P.572–579.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Criado G., Madrenas J. Superantigen Stimulation Reveals the Contribution of Lck to Negative Regulation of T Cell Activation // J. Immunology. — 2004. – Vol.172. — P.222–230.</mixed-citation><mixed-citation xml:lang="en">Criado G., Madrenas J. Superantigen Stimulation Reveals the Contribution of Lck to Negative Regulation of T Cell Activation // J. Immunology. — 2004. – Vol.172. — P.222–230.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Cunningham M.W. Pathogenesis of Group A Streptococcal Infections // Clin. Microbiol. Reviews. – 2000. — Vol. 13. — N 3. — P. 470–511.</mixed-citation><mixed-citation xml:lang="en">Cunningham M.W. Pathogenesis of Group A Streptococcal Infections // Clin. Microbiol. Reviews. – 2000. — Vol. 13. — N 3. — P. 470–511.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Donadini R., Liew C.W., Kwan A.H., Mackay J.P., Fields B.A. Crystal and solution structures of a superantigen from Yersinia pseudotuberculosis reveal a jelly–roll fold // Structure (Camb). — 2004. — Vol.12. — N 1. — P.145–156.</mixed-citation><mixed-citation xml:lang="en">Donadini R., Liew C.W., Kwan A.H., Mackay J.P., Fields B.A. Crystal and solution structures of a superantigen from Yersinia pseudotuberculosis reveal a jelly–roll fold // Structure (Camb). — 2004. — Vol.12. — N 1. — P.145–156.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Goodyear C.S., Silverman G.J. B cell superantigens: a microbe’s answer to innate–like B cells and natural antibodies // Springer Semin. Immunopathol. — 2005. — Vol.26. — N4. — P.463–484.</mixed-citation><mixed-citation xml:lang="en">Goodyear C.S., Silverman G.J. B cell superantigens: a microbe’s answer to innate–like B cells and natural antibodies // Springer Semin. Immunopathol. — 2005. — Vol.26. — N4. — P.463–484.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Huber B.T., Hsu P.–N., Sutkowski N. Virus–Encoded Superantigens // Microbiol. Reviews. — 1996. — Vol.60. — N 3. — P. 473–482.</mixed-citation><mixed-citation xml:lang="en">Huber B.T., Hsu P.–N., Sutkowski N. Virus–Encoded Superantigens // Microbiol. Reviews. — 1996. — Vol.60. — N 3. — P. 473–482.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Jie Y., Pan Z., Chen Y., Wei Y., Zhang W., Xu L., Wu Y., Peng H. SEB combined with IL–1ra could prolong the survival of the rat allografts in high–risk corneal transplantation // Transplant Proc. — 2004. — Vol.36. — N10. — P.3267–3271.</mixed-citation><mixed-citation xml:lang="en">Jie Y., Pan Z., Chen Y., Wei Y., Zhang W., Xu L., Wu Y., Peng H. SEB combined with IL–1ra could prolong the survival of the rat allografts in high–risk corneal transplantation // Transplant Proc. — 2004. — Vol.36. — N10. — P.3267–3271.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Li Z.S., Yang X.W., Chen Z., Dong H.L., Ye J., Qu P., Lu S.Y., Zhang X.M., Sui Y.F. In Vivo Tumor Co–Transfection with Superantigen and CD80 Induces Systemic Immunity without Tolerance and Prolongs Survival in Mice with Hepatocellular Carcinoma // Cancer Biol. Ther. — 2004. — Vol.3. — N7. — P. 660–666.</mixed-citation><mixed-citation xml:lang="en">Li Z.S., Yang X.W., Chen Z., Dong H.L., Ye J., Qu P., Lu S.Y., Zhang X.M., Sui Y.F. In Vivo Tumor Co–Transfection with Superantigen and CD80 Induces Systemic Immunity without Tolerance and Prolongs Survival in Mice with Hepatocellular Carcinoma // Cancer Biol. Ther. — 2004. — Vol.3. — N7. — P. 660–666.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Luxembourg A., Grey H. Strong induction of tyrosine phosphorylation, intracellular calcium, nuclear transcription factors and interferongamma, but weak induction of IL–2 in naive T cells stimulated by bacterial superantigen // Cell. Immunol. — 2002. — Vol.219. — N1. — P.28–37.</mixed-citation><mixed-citation xml:lang="en">Luxembourg A., Grey H. Strong induction of tyrosine phosphorylation, intracellular calcium, nuclear transcription factors and interferongamma, but weak induction of IL–2 in naive T cells stimulated by bacterial superantigen // Cell. Immunol. — 2002. — Vol.219. — N1. — P.28–37.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Meylan F., De Smedt M., Leclercq G., Plum J., Leupin O., Marguerat S., Conrad B. Negative thymocyte selection to HERV–K18 superantigens in humans // Blood. — 2005. — Vol.105. — P.4377–4382.</mixed-citation><mixed-citation xml:lang="en">Meylan F., De Smedt M., Leclercq G., Plum J., Leupin O., Marguerat S., Conrad B. Negative thymocyte selection to HERV–K18 superantigens in humans // Blood. — 2005. — Vol.105. — P.4377–4382.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Morgan M.M., Labno C.M., Van Seventer G.A., Denny M.F., Straus D.B., Burkhardt J.K. Superantigen–Induced T Cell:B Cell Conjugation Is Mediated by LFA–1 and Requires Signaling Through Lck, But Not ZAP–701 // The Journal of Immunology. — 2001. — Vol.167. — P.5708–5718.</mixed-citation><mixed-citation xml:lang="en">Morgan M.M., Labno C.M., Van Seventer G.A., Denny M.F., Straus D.B., Burkhardt J.K. Superantigen–Induced T Cell:B Cell Conjugation Is Mediated by LFA–1 and Requires Signaling Through Lck, But Not ZAP–701 // The Journal of Immunology. — 2001. — Vol.167. — P.5708–5718.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Niedergang F., Dautry–Varsat A., Alcover A. Cooperative Activation of TCRs by Enterotoxin Superantigens // J. Immunolog. — 1998. — Vol. 161. — P.6054–6058.</mixed-citation><mixed-citation xml:lang="en">Niedergang F., Dautry–Varsat A., Alcover A. Cooperative Activation of TCRs by Enterotoxin Superantigens // J. Immunolog. — 1998. — Vol. 161. — P.6054–6058.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Papageorgiou A.C., Baker M.D., McLeod J.D., Goda S.K., Manzotti C.N., Sansom D.M., Tranter H.S., Acharya K. R. Identification of a Secondary Zinc–binding Site in Staphylococcal Enterotoxin C2 // J. Biol. Chem. — 2004. — Vol.279. — N.2. — P.1297–1303.</mixed-citation><mixed-citation xml:lang="en">Papageorgiou A.C., Baker M.D., McLeod J.D., Goda S.K., Manzotti C.N., Sansom D.M., Tranter H.S., Acharya K. R. Identification of a Secondary Zinc–binding Site in Staphylococcal Enterotoxin C2 // J. Biol. Chem. — 2004. — Vol.279. — N.2. — P.1297–1303.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Perabo F.G., Willert P.L., Wirger A, Schmidt D.H., Wardelmann E., Sitzia M., von Ruecker A., Mueller S.C. Preclinical evaluation of superantigen (staphylococcal enterotoxin B) in the intravesical immunotherapy of superficial bladder cancer // Int J Cancer. — 2005 – Vol. 115. — N4. — P.591–598.</mixed-citation><mixed-citation xml:lang="en">Perabo F.G., Willert P.L., Wirger A, Schmidt D.H., Wardelmann E., Sitzia M., von Ruecker A., Mueller S.C. Preclinical evaluation of superantigen (staphylococcal enterotoxin B) in the intravesical immunotherapy of superficial bladder cancer // Int J Cancer. — 2005 – Vol. 115. — N4. — P.591–598.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Petersson K., Forsberg G., Walse B. Interplay between superantigens and immunoreceptors // Scand. J. Immunol. — 2004. — Vol.59. — N4. — P.345–355.</mixed-citation><mixed-citation xml:lang="en">Petersson K., Forsberg G., Walse B. Interplay between superantigens and immunoreceptors // Scand. J. Immunol. — 2004. — Vol.59. — N4. — P.345–355.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Plaza R., Vidal S., Rodriguez–Sanchez J. L., Juarez C. Implication of STAT1 and STAT3 transcription factors in the response to superantigens // Cytokine. — 2004. — Vol.25. — N1. — P.1–10.</mixed-citation><mixed-citation xml:lang="en">Plaza R., Vidal S., Rodriguez–Sanchez J. L., Juarez C. Implication of STAT1 and STAT3 transcription factors in the response to superantigens // Cytokine. — 2004. — Vol.25. — N1. — P.1–10.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Torres B.A., Perrin G.Q., Mujtaba M.G., Subramaniam P.S., Anderson A.K., Johnson H.M. Superantigen enhancement of specific immunity: antibody production and signaling pathways // J. Immunol. — 2002. – Vol.169. — N6. — P.2907–2914.</mixed-citation><mixed-citation xml:lang="en">Torres B.A., Perrin G.Q., Mujtaba M.G., Subramaniam P.S., Anderson A.K., Johnson H.M. Superantigen enhancement of specific immunity: antibody production and signaling pathways // J. Immunol. — 2002. – Vol.169. — N6. — P.2907–2914.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Viau M., Cholley B., Bjorck L., Zouali M. Down–modulation of the antigen receptor by a superantigen for human B cells // Immunol. Lett. — 2004. — Vol.92. — N1–2. — P.91–96.</mixed-citation><mixed-citation xml:lang="en">Viau M., Cholley B., Bjorck L., Zouali M. Down–modulation of the antigen receptor by a superantigen for human B cells // Immunol. Lett. — 2004. — Vol.92. — N1–2. — P.91–96.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Xu G.L., Zhu X.H., Guo B, Wu Y.Z. Involvement of CTLA–4 in T–cell anergy induced by staphylococcal enterotoxin A in vitro // Mol. Immunol.– 2004. – Vol.41. — N1. — P.1–8.</mixed-citation><mixed-citation xml:lang="en">Xu G.L., Zhu X.H., Guo B, Wu Y.Z. Involvement of CTLA–4 in T–cell anergy induced by staphylococcal enterotoxin A in vitro // Mol. Immunol.– 2004. – Vol.41. — N1. — P.1–8.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Zhao Y., Li Z., Drozd S.J., Guo Y., Mourad W., Li H. Crystal structure of Mycoplasma arthritidis mitogen complexed with HLA–DR1 reveals a novel superantigen fold and a dimerized superantigen–MHC complex // Structure (Camb.). — 2004. — Vol.12. — N2. — P.277–288.</mixed-citation><mixed-citation xml:lang="en">Zhao Y., Li Z., Drozd S.J., Guo Y., Mourad W., Li H. Crystal structure of Mycoplasma arthritidis mitogen complexed with HLA–DR1 reveals a novel superantigen fold and a dimerized superantigen–MHC complex // Structure (Camb.). — 2004. — Vol.12. — N2. — P.277–288.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
